Abstract
Enhanced receptor selectivity: carbonic anhydrase inhibitors are relevant for both cancer diagnosis and therapy. Combining non-radioactive Re compounds with their radioactive (99m)Tc homologs enables the use of identical molecules for therapy and imaging (theragnostic). The syntheses and in vitro evaluation of [(Cp-R)M(CO)(3)] (Cp=cyclopentadienyl, M=Re, (99m)Tc) with R being a highly potent carbonic-anhydrase-targeting vector is reported.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, Neoplasm / chemistry*
-
Antigens, Neoplasm / metabolism
-
Carbonic Anhydrase IX
-
Carbonic Anhydrase Inhibitors / chemistry*
-
Carbonic Anhydrase Inhibitors / pharmacology
-
Carbonic Anhydrases / chemistry*
-
Carbonic Anhydrases / metabolism
-
Cell Proliferation / drug effects
-
Coordination Complexes / chemistry
-
Coordination Complexes / pharmacology
-
HEK293 Cells
-
HeLa Cells
-
Humans
-
Hydrogen-Ion Concentration
-
Organotechnetium Compounds / chemistry
-
Rhenium / chemistry
-
Sulfonamides / chemistry*
-
Sulfonic Acids / chemistry*
-
Tamoxifen / chemistry
Substances
-
Antigens, Neoplasm
-
Carbonic Anhydrase Inhibitors
-
Coordination Complexes
-
Organotechnetium Compounds
-
Sulfonamides
-
Sulfonic Acids
-
Tamoxifen
-
Rhenium
-
sulfamic acid
-
CA9 protein, human
-
Carbonic Anhydrase IX
-
Carbonic Anhydrases